STEWARTVILLE, MN (trfnews.i234.me) – United Therapeutics, a biotechnology company renowned for its groundbreaking work in organ engineering, is investing $100 million in a new research facility in Stewartville, Minnesota.
This state-of-the-art center will focus on producing human-compatible hearts and kidneys using genetically engineered pigs. Located just 10 miles south of Rochester, the tightly controlled facility will oversee every aspect of the pigs’ lives, from birth to harvest, ensuring the highest biocurity standards.
United Therapeutics aims to begin human trials as early as next year, advancing the potential for life-saving transplants.